Faron Pharmaceuticals Oy (FARN)

Company name:	Faron Pharmaceuticals Oy
EPIC:	FARN	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	FI4000153309
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.faronpharmaceuticals.com/	Description:	ORD NPV (DI)
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Faron Pharmaceuticals Oy Key Figures

(at previous day's close)
Market Cap.	196.79	m
Shares In Issue	50.46	m
Prev. Close	392.50
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-31.73	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-30.86	p
Return On Equity (ROE)	-	%
Operating Margin	-	%
PEG Factor	-
EPS Growth Rate	-19.35	%
Dividends PS Growth Rate	-	%
Net Debt	5.44	m
Gross Gearing	122.10	%
Quick Assets	6.62	m
Net Working Capital	0.82	m
Intangibles / Fixed Assets	98.51	%
Turnover PS	-	p
Pre-Tax Profit PS	-29.90	p
Retained Profit PS	-2.91	p
Cash PS	7.25	p
Net Cash PS	-4.23	p
Net Tangible Asset Value PS *	-4.90	p
Net Asset Value PS	-3.26	p
Spread	20.00 (5.00%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	375.00	15.00	4.00	367.50	0.03		391.74
4 weeks	377.50	12.50	3.31	353.25	0.02		379.00
12 weeks	362.50	27.50	7.59	321.50	0.02		358.15
26 weeks	285.00	105.00	36.84	220.00	0.04		357.37
1 year	352.50	37.50	10.64	220.00	0.04		371.21
3 years	65.50	324.50	495.42	51.00	0.13		163.76
5 years	270.00	120.00	44.44	51.00	0.11		181.27
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	21.19
Tobin's Q Ratio (excl. intangibles)	23.52
Dividend Yield	-	%
Market-to-Book Ratio	-119.45
Price-to-Pre-Tax Profit PS	-13.04
Price-to-Retained Profit PS	-134.19
Price-to-Cash Flow PS	-12.64
Price-to-Sales PS	-
Price-to-Net Tangible Asset Value PS	-79.59
Price-to-Cash PS	53.77
Net Working Capital PS	1.63
Price Pct to Working Capital PS	239.04	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	199.20	%
Debt-to-Equity Ratio	-2.01
Debt-to-Equity Ratio (excl. Intgbl)	-1.34
Debt-to-Equity Market Value	0.02
Net Gearing	73.00	%
Net Gearing (excl. Intangibles)	82.09	%
Gross Gearing	122.10	%
Gross Gearing (excl. Intangibles)	137.29	%
Gearing Under 1 Year	77.72	%
Gearing Under 1 Year (excl. Intgbl)	87.39	%
Assets/Equity	-4.53
Cash/Equity	-222.17
(Liquidity Ratios)
Net Working Capital to Total Assets	11.04	%
Current Ratio	1.14
Quick Ratio (Acid Test)	1.14
Liquidity Ratio	0.63
Cash & Equiv/Current Assets	55.31	%
(Solvency Ratios)
Enterprise Value	196.43	m
CFO/Sales	-
CFO/Attributable Profit	-
CFO/Assets	-2.09
CFO/Debt	-1.71
Total Debt/Equity Market Value	0.05
Total Debt/Sales	-
Total Debt/Pre-Tax Profit	-0.60
Total Debt	9.10	m
Total Debt/Net Current Assets	11.06	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-17.12	%
5 yr Compound Earnings Growth	-1.05	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	3

Beta (60-Mnth)	Beta (36-Mnth)
0.0788	-0.2595

(Profitability Ratios)
Return On Capital Employed (ROCE)	-908.58	%
Return On Assets (ROA)	-162.55	%
Net Profit Margin	-	%
Assets Turnover	-
Return On Equity (ROE)	-	%
Return On Investment (ROI)	-503.43	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	-
Fixed Assets Turnover	-
Current Assets Turnover	-
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	-
Debtors-to-Sales	-	%
Debt Collection Period	-	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.